KPV

Laboratory Handling Directions

• Store at controlled room temperature (15–25°C / 59–77°F)
• Protect from light and moisture during storage
• Use aseptic technique when handling compound
• Reconstitute with bacteriostatic water as appropriate
• Once reconstituted, refrigerate at 2–8°C (36–46°F)
• Document all handling procedures per laboratory protocols
  

Mechanism of Action

KPV research peptide exerts its effects primarily through intracellular mechanisms, including uptake via the PepT1 transporter in epithelial and immune cells, followed by inhibition of NF-κB activation and MAPK signaling pathways. Furthermore, it stabilizes IκBα, suppresses nuclear translocation of p65RelA, and reduces pro-inflammatory cytokine production such as TNF-α and IL-8. Additionally, KPV modulates oxidative stress responses, decreases ROS generation, and influences apoptosis-related proteins in various cellular models. Laboratory investigations, including those on intestinal epithelial cells and keratinocytes, reveal its ability to shorten the NF-κB activation duration and promote anti-inflammatory balance. These actions can contribute to observed effects in all models of inflammation and tissue damage, with recent research emphasizing its reassuring potential for targeted modulation in gut and skin-related pathways.

Research Applications

• Anti-inflammatory pathway investigations

• NF-κB and MAPK signaling mechanism analysis

• Intestinal epithelial cell inflammation studies

• Cytokine modulation research (TNF-α, IL-8)

• Mucosal healing and barrier function evaluations Oxidative stress and apoptosis pathway examinations in inflammatory models

Scientific References

• Dalmasso G et al. Gastroenterology. 2008;134(1):166-178. 

• Xiao B et al. Mol Ther. 2017;25(6):1628-1640. 

• Land SC et al. Int J Physiol Pathophysiol Pharmacol. 2012;4(2):59-73. 

• Kannengiesser K et al. Inflamm Bowel Dis. 2008;14(3):324-331. 

• Sung J et al. Environ Toxicol Pharmacol. 2025;117:104117.